Penina Haber

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Vaccines and Guillain-Barré syndrome
    Penina Haber
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Drug Saf 32:309-23. 2009
  2. ncbi request reprint An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Penina Haber
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 113:e353-9. 2004
  3. ncbi request reprint Guillain-Barré syndrome following influenza vaccination
    Penina Haber
    Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 292:2478-81. 2004
  4. doi request reprint Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety
    Penina Haber
    Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S39-44. 2011
  5. doi request reprint Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012
    Penina Haber
    National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Pediatrics 131:1042-9. 2013
  6. doi request reprint Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 54:1608-14. 2012
  7. doi request reprint Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007
    Penina Haber
    Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
    Pediatrics 121:1206-12. 2008
  8. doi request reprint Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
    Armenak Asatryan
    Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
    Vaccine 26:1166-72. 2008
  9. doi request reprint Death and serious illness following influenza vaccination: a multidisciplinary investigation
    Alison Rue-Cover
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 18:504-11. 2009
  10. doi request reprint Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 204:146.e1-7. 2011

Detail Information

Publications29

  1. doi request reprint Vaccines and Guillain-Barré syndrome
    Penina Haber
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Drug Saf 32:309-23. 2009
    ..However, the benefit of vaccines in preventing disease and decreasing morbidity and mortality, particularly for influenza, needs to be weighed against the potential risk of GBS...
  2. ncbi request reprint An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Penina Haber
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 113:e353-9. 2004
    ....
  3. ncbi request reprint Guillain-Barré syndrome following influenza vaccination
    Penina Haber
    Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 292:2478-81. 2004
    ..Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990...
  4. doi request reprint Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety
    Penina Haber
    Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S39-44. 2011
    ....
  5. doi request reprint Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012
    Penina Haber
    National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Pediatrics 131:1042-9. 2013
    ..In 2006 and 2008, 2 new rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) were introduced in the United States...
  6. doi request reprint Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 54:1608-14. 2012
    ..We characterized clinical patterns of reports to the Vaccine Adverse Event Reporting System (VAERS) among older adults who received TIV-HD...
  7. doi request reprint Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007
    Penina Haber
    Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
    Pediatrics 121:1206-12. 2008
    ..Although the new rotavirus vaccine (RotaTeq; Merck, West Point, PA) introduced in 2006 was not associated with intussusception in prelicensure trials, additional monitoring is important to ensure a complete safety profile...
  8. doi request reprint Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
    Armenak Asatryan
    Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
    Vaccine 26:1166-72. 2008
    ..Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL...
  9. doi request reprint Death and serious illness following influenza vaccination: a multidisciplinary investigation
    Alison Rue-Cover
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 18:504-11. 2009
    ..All had received vaccine from the same lot (Lot A)...
  10. doi request reprint Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 204:146.e1-7. 2011
    ..The objective of the study was to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) in pregnant women who received seasonal influenza vaccines to assess for potential vaccine safety concerns...
  11. doi request reprint Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring
    Claudia Vellozzi
    Immunization Safety Office ISO, Office of the Chief Science Officer OCSO, Centers for Disease Control and Prevention, Atlanta, GA, United States
    Vaccine 27:2114-20. 2009
    ..No new safety concerns emerged after our review of 15 years of post-licensure surveillance data. These findings provide useful information if pandemic vaccine is rapidly distributed and pre-licensure data are limited...
  12. doi request reprint Intussusception and rotavirus vaccination: a review of the available evidence
    Manish M Patel
    Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Expert Rev Vaccines 8:1555-64. 2009
    ..We review these safety data for the new vaccines and for Rotashield to provide background information relevant for considering age recommendations for rotavirus vaccination...
  13. doi request reprint Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 29:9404-8. 2011
    ..Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was not licensed for use in adults aged ≥65 years due to lack of sufficient efficacy and safety data...
  14. pmc Monitoring vaccine safety during an influenza pandemic
    John Iskander
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Yale J Biol Med 78:265-75. 2005
    ..Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic...
  15. doi request reprint Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010
    Claudia Vellozzi
    Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 28:7248-55. 2010
    ..Death, Guillain-Barré syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered)...
  16. ncbi request reprint A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001
    Weigong Zhou
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 13:505-10. 2004
    ..We reviewed reports in the Vaccine Adverse Event Reporting System (VAERS) to assess if parenteral inactivated influenza vaccines (influenza vaccines) may also increase the risk for Bell's palsy...
  17. doi request reprint Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 205:473.e1-9. 2011
    ....
  18. doi request reprint Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
    Yenlik A Zheteyeva
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Am J Obstet Gynecol 207:59.e1-7. 2012
    ..We sought to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) of pregnant women who received tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)...
  19. ncbi request reprint Adverse event reports following vaccination for Lyme disease: December 1998-July 2000
    Sarah L Lathrop
    Centers for Disease Control and Prevention, Epidemic Intelligence Service, Atlanta, GA 30333, USA
    Vaccine 20:1603-8. 2002
    ..Although events reported to VAERS are not necessarily causally associated with vaccination, VAERS reports can be used to identify possible safety concerns that occur at too low a rate to have been identified prior to licensure...
  20. ncbi request reprint Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
    Anthony E Fiore
    Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 56:1-54. 2007
    ..Immunization providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information...
  21. doi request reprint Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 197:S170-7. 2008
    ..Ongoing safety surveillance and further studies may shed light on some of the hypothesized associations...
  22. ncbi request reprint Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001
    Weigong Zhou
    Epidemic Intelligence Service Program, Epidemiology Program Office, CDC, USA
    MMWR Surveill Summ 52:1-24. 2003
    ..Therefore, postmarketing monitoring of adverse events after vaccinations is essential. The cornerstone of monitoring safety is review and analysis of spontaneously reported adverse events...
  23. ncbi request reprint Influenza vaccination and Guillain Barré syndrome
    Penina Haber
    Clin Immunol 109:359; author reply 360-1. 2003
  24. ncbi request reprint Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003
    Ann W McMahon
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852, USA
    Pediatrics 115:453-60. 2005
    ..In April 2002, the Advisory Committee on Immunization Practices (ACIP) encouraged providers to vaccinate healthy 6- to 23-month-old infants and children with trivalent influenza vaccine (TIV)...
  25. ncbi request reprint Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004
    Penina Haber
    Vaccine 25:8101. 2007
  26. ncbi request reprint Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002
    Elizabeth M Begier
    Vaccine Safety Branch, Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852 1448, USA
    Clin Infect Dis 38:771-9. 2004
    ..Nonfatal anaphylaxis was reported after both vaccines. VAERS reports do not indicate any unexpected serious side effects that compromise these vaccines' use for travelers' prophylaxis...
  27. ncbi request reprint Adverse events reported following live, cold-adapted, intranasal influenza vaccine
    Hector S Izurieta
    Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852 1448, USA
    JAMA 294:2720-5. 2005
    ..Although prelicensure testing involved 20 228 vaccinees, clinical trials were not of sufficient size to detect rare adverse events reliably...
  28. ncbi request reprint Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997
    Jenifer C Lloyd
    Office of Epidemiology, Utah Department of Health, Bureau for Children with Special Health Care Needs, P O Box 144640, Salt Lake City, UT 84114 4640, USA
    Vaccine 21:3746-50. 2003
    ..While reporting rates are lower after TT than Td, rates of reported VAEs after both vaccines are low...
  29. ncbi request reprint Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Rafael Harpaz
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, USA
    MMWR Recomm Rep 57:1-30; quiz CE2-4. 2008
    ..Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity...